A randomised controlled trial to assess the efficacy of dihydroartemisinin-piperaquine for the treatment of uncomplicated falciparum malaria in Peru by Grande, T, Bernasconi, A, Erhart, A, Gamboa, D, Casapia, M, Delgado, C, Torres, K, Fanello, C, Llanos-Cuentas, A, D'Alessandro, U

Tafenoquine versus primaquine to prevent relapse of Plasmodium vivax malaria by Llanos-Cuentas, A, Lacerda, MVG, Hien, TT, Vélez, ID, Namaik-Larp, C, Chu, CS, Villegas, MF, Val, F, Monteiro, WM, Brito, MAM, Costa, MRF, Chuquiyauri, R, Casapía, M, Nguyen, CH, Aruachan, S, Papwijitsil, R, Nosten, FH, Bancone, G, Angus, B, Duparc, S, Craig, G, Rousell, VM, Jones, SW, Hardaker, E, Clover, DD, Kendall, L, Mohamed, K, Koh, GCKW, Wilches, VM, Breton, JJ, Green, JA

Single-dose tafenoquine to prevent relapse of Plasmodium vivax malaria by Lacerda, MVG, Llanos-Cuentas, A, Krudsood, S, Lon, C, Saunders, DL, Mohammed, R, Yilma, D, Batista Pereira, D, Espino, FEJ, Mia, RZ, Chuquiyauri, R, Val, F, Casapía, M, Monteiro, WM, Brito, MAM, Costa, MRF, Buathong, N, Noedl, H, Diro, E, Getie, S, Wubie, KM, Abdissa, A, Zeynudin, A, Abebe, C, Tada, MS, Brand, F, Beck, H-P, Angus, B, Duparc, S, Kleim, J-P, Kellam, LM, Rousell, VM, Jones, SW, Hardaker, E, Mohamed, K, Clover, DD, Fletcher, K, Breton, JJ, Ugwuegbulam, CO, Green, JA, Koh, GCKW